Innovision’s ₹319.25 crore initial public offering appears headed for a discounted listing, with grey market premium (GMP) signals pointing to significant weakness in investor demand.
The IPO, which had a price band of ₹494-₹519 per share, is indicating a listing price of ₹459 per share based on current GMP data. This represents an 11.56% discount from the upper end of the price band, suggesting limited investor enthusiasm for the public issue.
After six days of bidding, the IPO remained undersubscribed, indicating that overall demand has not met expectations. However, qualified institutional buyers (QIBs) have shown relatively stronger participation, with bids from this category exceeding the shares offered in their portion.
The weak GMP reading reflects broader market caution towards the offering. While institutional investors have been active, retail and high net-worth individual (HNI) participation appears subdued, contributing to the overall tepid demand.
GMP serves as an indicator of market sentiment ahead of listing, though it does not guarantee actual listing prices. A negative or weak GMP often signals that the IPO may list below its offer price, resulting in listing day losses for allottees.
Investors who have applied for Innovision’s IPO should monitor the final subscription data and manage expectations accordingly, as the grey market indicators suggest a challenging debut on the bourses.
Source: Read original